Dr. A. Bruce Montgomery, also known as Bruce, has been making waves in the biotech industry for over 25 years. He joined the board of Xencor, Inc. in March 2015 and has impressive experience in drug development and operations. He...

Dr. A. Bruce Montgomery, also known as Bruce, has been making waves in the biotech industry for over 25 years. He joined the board of Xencor, Inc. in March 2015 and has impressive experience in drug development and operations. He played a crucial role in bringing Cayston to cystic fibrosis patients while working at Gilead Sciences. He's led several biotech companies, including Corus Pharma, which he founded. Dr. Montgomery has also held significant positions in renowned firms like Genentech and Pathogenesis. His educational background includes a B.S. in Chemistry and an M.D. from the University of Washington. Apart from his hands-on experience, he's also served on various boards like Alder Biopharmaceuticals and Cytodyn, Inc. Recently, his insider trading activities show fluctuations in his holdings, indicating a proactive approach to managing his investments, with recent values peaking at around $451.20K. Dr. Montgomery emphasizes performance-driven results, both in his investments and in leading teams towards executing corporate goals.